ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 113 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $189,328 | -9.5% | 26,779 | +76.0% | 0.00% | – |
| Q1 2024 | $209,234 | +69.3% | 15,217 | +13.3% | 0.00% | – |
| Q4 2023 | $123,565 | +80.6% | 13,431 | +18.8% | 0.00% | – |
| Q3 2023 | $68,420 | -46.5% | 11,309 | -31.4% | 0.00% | – |
| Q2 2023 | $127,885 | +1093.4% | 16,480 | +776.6% | 0.00% | – |
| Q1 2023 | $10,716 | +305.1% | 1,880 | +318.7% | 0.00% | – |
| Q4 2022 | $2,645 | +32.2% | 449 | +1.1% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 444 | -15.3% | 0.00% | – |
| Q2 2022 | $2,000 | -99.8% | 524 | -99.7% | 0.00% | – |
| Q1 2022 | $953,000 | -64.4% | 178,327 | -2.1% | 0.00% | -100.0% |
| Q4 2021 | $2,677,000 | -89.4% | 182,161 | -84.9% | 0.00% | -83.3% |
| Q3 2021 | $25,276,000 | +15.1% | 1,208,792 | -2.6% | 0.01% | +20.0% |
| Q2 2021 | $21,958,000 | -25.5% | 1,241,281 | +3.1% | 0.01% | -28.6% |
| Q1 2021 | $29,491,000 | +2.0% | 1,203,741 | +41.0% | 0.01% | 0.0% |
| Q4 2020 | $28,901,000 | +85.2% | 853,806 | +36.8% | 0.01% | +75.0% |
| Q3 2020 | $15,605,000 | -19.0% | 623,936 | +9.3% | 0.00% | -33.3% |
| Q2 2020 | $19,258,000 | – | 570,961 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 496,893 | $16,760,000 | 14.90% |
| Svennilson Peter | 4,768,181 | $160,831,000 | 13.45% |
| Invus Financial Advisors, LLC | 1,007,576 | $33,986,000 | 12.28% |
| EcoR1 Capital, LLC | 2,642,218 | $89,122,000 | 6.58% |
| Foresite Capital Management IV, LLC | 125,000 | $4,216,000 | 2.05% |
| Orbimed Advisors | 2,921,967 | $98,558,000 | 1.39% |
| Casdin Capital, LLC | 251,515 | $8,484,000 | 0.50% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 191,568 | $6,462,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 300,000 | $10,119,000 | 0.30% |
| EMERALD ADVISERS, LLC | 186,140 | $6,279,000 | 0.27% |